Gene · 5976
Papers2,361
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,361
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Restoration of functional PAX6 in aniridia patient iPSC-derived ocular tissue models using repurposed nonsense suppression drugs. | Mol Ther Nucleic Acids | 2023 | 37483273 | PubTator, text mining | PubMed |
| Correction to Long non-coding RNA SNAI3-AS1 promotes the proliferation and metastasis of hepatocellular carcinoma by regulating the UPF1/Smad7 signalling pathway. | J Cell Mol Med | 2023 | 37477384 | PubTator, text mining | PubMed |
| Cytoskeleton remodeling mediated by circRNA-YBX1 phase separation suppresses the metastasis of liver cancer. | Proc Natl Acad Sci U S A | 2023 | 37459535 | PubTator, text mining | PubMed |
| The identification of protein and RNA interactors of the splicing factor Caper in the adult Drosophila nervous system. | Front Mol Neurosci | 2023 | 37435576 | PubTator, text mining | PubMed |
| Mapping genetic variants for nonsense-mediated mRNA decay regulation across human tissues. | Genome Biol | 2023 | 37434206 | PubTator, text mining | PubMed |
| Blood RNA-Seq profiling reveals a set of circular RNAs differentially expressed in frail individuals. | Immun Ageing | 2023 | 37434183 | PubTator, text mining | PubMed |
| High glucose-upregulated PD-L1 expression through RAS signaling-driven downregulation of PTRH1 leads to suppression of T cell cytotoxic function in tumor environment. | J Transl Med | 2023 | 37434177 | PubTator, text mining | PubMed |
| Characterization of the alternative splicing landscape in lung adenocarcinoma reveals novel prognosis signature associated with B cells. | PLoS One | 2023 | 37432957 | PubTator, text mining | PubMed |
| Emerging roles of tRNA-derived small RNAs in cancer biology. | Exp Mol Med | 2023 | 37430089 | PubTator, text mining | PubMed |
| Cyclin E/CDK2 and feedback from soluble histone protein regulate the S phase burst of histone biosynthesis. | Cell Rep | 2023 | 37428633 | PubTator, text mining | PubMed |
| Intronic small nucleolar RNAs regulate host gene splicing through base pairing with their adjacent intronic sequences. | Genome Biol | 2023 | 37415181 | PubTator, text mining | PubMed |
| Zika Virus Induces Degradation of the Numb Protein Required through Embryonic Neurogenesis. | Viruses | 2023 | 37376558 | PubTator, text mining | PubMed |
| The Roles of Zinc Finger Proteins in Colorectal Cancer. | Int J Mol Sci | 2023 | 37373394 | PubTator, text mining | PubMed |
| Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development. | Biomolecules | 2023 | 37371567 | PubTator, text mining | PubMed |
| Upf3a but not Upf1 mediates the genetic compensation response induced by leg1 deleterious mutations in an H3K4me3-independent manner. | Cell Discov | 2023 | 37369707 | PubTator, text mining | PubMed |
| Convergence of multiple RNA-silencing pathways on GW182/TNRC6. | Mol Cell | 2023 | 37369201 | PubTator, text mining | PubMed |
| Nonsense-mediated decay machinery in Plasmodium falciparum is inefficient and non-essential. | mSphere | 2023 | 37366629 | PubTator, text mining | PubMed |
| Destabilized 3'UTR elements therapeutically degrade ERBB2 mRNA in drug-resistant ERBB2+ cancer models. | Front Genet | 2023 | 37359373 | PubTator, text mining | PubMed |
| Characterization of a rhabdomyosarcoma reveals a critical role for SMG7 in cancer cell viability and tumor growth. | Sci Rep | 2023 | 37349371 | PubTator, text mining | PubMed |
| A mutation in the coronavirus nsp13-helicase impairs enzymatic activity and confers partial remdesivir resistance. | mBio | 2023 | 37338298 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5976/papers?page=13